Impact of phase II trials with progression-free survival as end-points on survival-based phase III studies in patients with anaplastic gliomas.
| Autor: | Levin, Victor A.1 vlevin@mdanderson.org, Ictech, Sandra1 sictech@mdanderson.org, Hess, Kenneth R.2 khess@mdanderson.org |
|---|---|
| Zdroj: | BMC Cancer. 2007, Vol. 7, p106-7. 7p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|